2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Bladder Cancer
Bladder cancer remains a significant focus of cancer research due to its prevalence and impact on public health. Studies delve into various aspects, from understanding its molecular mechanisms to exploring innovative treatment modalities. Researchers investigate genetic predispositions, environmental factors, and lifestyle influences contributing to its development. Advanced imaging techniques aid in early detection, enhancing prognosis and treatment outcomes. Immunotherapy, targeted therapies, and personalized medicine are promising avenues, aiming for improved efficacy and reduced side effects. Additionally, ongoing efforts emphasize the importance of patient education, early screening programs, and support networks. Collaborative endeavors between clinicians, scientists, and advocacy groups drive progress in bladder cancer research, ultimately aiming for better prevention, detection, and treatment strategies.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China